Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
about
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbsDrug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to dateKorean Guidelines for Interventional Recanalization of Lower Extremity ArteriesCritical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial diseaseThe effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.Critical limb ischemia: current approach and future directions.Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcomeTreating femoropopliteal disease: established and emerging technologiesManagement of Critical Limb Ischemia.The Diagnosis and Treatment of Peripheral Arterial Vascular Disease.Drug-coated balloons and their place in treating peripheral arterial disease.Drug-coated balloon therapy in coronary and peripheral artery disease.Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized TrialDrug-coated balloons: how should we incorporate into our practice in treating superficial femoral artery lesions?Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.Drug coated balloon angioplasty in the treatment of peripheral artery disease.Peripheral Vascular Restenosis: A Retrospective Study on the Use of Drug-Eluting Balloons in Native Arteries, Vein Grafts and Dialysis Accesses.How should recent endovascular trials for femoropopliteal artery disease be interpreted?[Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center.Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries.Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients.Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts.Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.Comparison of immediate and 2-year outcomes between excimer laser-assisted angioplasty with spot stent and primary stenting in intermediate to long femoropopliteal disease.Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry.Treatment of Femoropopliteal Artery In-stent Restenosis.Heparin-Bonded Viabahn and Drug-Eluting Bare Metal Zilver (PTX) Sandwich Stents in Femoral Chronic Total Occlusion: A Retrospective Review of Mid-Term and Long-Term Outcomes
P2860
Q26470510-5EFF6F52-9425-4978-BB9E-DCC1765780FCQ26747772-631EB58F-61ED-453E-80BC-7E1F90A4E0F7Q26801709-D7AA8C80-3F5E-4008-A102-5732A24A5FC3Q28080110-DECFC483-DD9C-4A74-A5DC-57F3EC7C19A1Q30313782-1BD0D7A0-573E-49AD-8322-C81B15542A1DQ30458139-0D5F155C-21E3-42E3-94F6-BFADBB6E4036Q33826534-C91252FB-3592-41D0-8449-7B3324B9826EQ34513862-0BAE6762-3846-47A4-A7A5-B4E9F54EC751Q36786241-4189F8B4-1FD5-47E1-8697-E300BB58F961Q37492857-63702A78-AEA0-463B-BB85-D797FA9AD6CDQ38070705-B65DE3E1-3FBF-45F6-9840-038EC4485522Q38159879-2A27C42A-D618-406B-9751-09CCFA356B1BQ38203809-4B1FEF37-01B2-4E56-B3D4-1662F421E3F2Q38373320-4ABF0FA6-3F04-43D7-AED7-374168CC515BQ38386381-1C604765-3301-4912-90F2-7A131F64BE5EQ38502277-FAB0ABD5-5D53-48BA-8AB6-F43C6D34392FQ38560053-282CD7DB-8D92-4009-B291-8FB3915139B8Q38827478-E7229A0E-43B3-4373-B2CF-B1A402DF9EBFQ38857161-14976568-D0F2-4197-8BC4-3F30DA608B3CQ38934274-B21E1D2C-6487-4971-89B1-B8CDE7490B26Q40905783-6DD5A5A7-A46F-4485-9F56-5E4EE48F868FQ41439581-CC5E8197-A663-4E37-8DD2-3CBB343A861BQ44281721-699932D2-34FA-44BD-92EA-02538D257CE6Q45751067-545B9D65-1011-49F8-9F4C-8A3F515FED59Q48103282-A02E02CC-B0B6-403B-9001-5392C41CF650Q50955909-06A7C420-7974-4E57-BC89-C9C99CE1EF14Q51820972-B13D770F-97F1-48E0-A2A6-191FF4F603A0Q52576939-C1198EB5-339C-4D78-A6CF-7AB888711E37Q54381197-473B319C-2975-4B1A-81DE-40D486AAD82CQ55020100-216D8BE2-E31C-4875-8092-7C1459BD9298Q55422201-0F786687-C1C9-49C2-BAD8-7722C5ED6FC2Q58046019-8BBFF1A1-236D-4D53-8A8C-BB6E7393C916
P2860
Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@en
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@nl
type
label
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@en
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@nl
prefLabel
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@en
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@nl
P2093
P1476
Paclitaxel-coated versus uncoa ...... analysis of randomized trials.
@en
P2093
Gjin Ndrepepa
Massimiliano Fusaro
Mateja Nerad
Robert A Byrne
Salvatore Cassese
P304
P356
10.1161/CIRCINTERVENTIONS.112.969972
P577
2012-07-31T00:00:00Z